Our data showed that SFN-treated thyroid cancer cells were arrested in G2/M phase, which was accompanied by a decline in the levels of Cdk1, Cdk2, Cyclin B1 and Cdc25C and an increase in the levels of Chk1 and p21. Here, CDC25C is linked to thyroid cancer.